Palo Alto Networks Inc.

08/21/2026 | Press release | Distributed by Public on 08/21/2026 14:15

Amendments to Bylaws, Management Change/Compensation (Form 8-K)

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 20, 2026, the Board of Directors (the "Board") of Palo Alto Networks, Inc. (the "Company"), upon the recommendation of the Compensation and People Committee of the Board, approved an Executive Change in Control and Severance Policy (the "Policy"). The Policy is designed to provide certain severance benefits to selected participants in connection with the involuntary termination of the participant's employment during a specified change in control protection period, or, in certain cases, outside of a change in control protection period. Company employees with the title of Senior Vice President and above who execute a participation agreement with the Company have been designated as participants in the Policy, including the following executives: Nikesh Arora, the Company's Chairman and Chief Executive Officer (the "CEO"), Dipak Golechha, the Company's Chief Financial Officer, William "BJ" Jenkins, the Company's President, and Lee Klarich, the Company's Chief Product and Technology Officer.

Under the terms of the Policy, if an executive's employment is terminated by the Company other than for "Cause," death or "Disability" (each, as defined in the Policy) outside of the period beginning three months prior to a Change in Control (as defined in the Policy) and ending 12 months (or 18 months for the CEO) following a Change in Control (the "CIC Period"), then, subject to the executive's timely execution and non-revocation of a separation agreement and release of claims with the Company, the executive will receive: (i) salary severance equal to a percentage (as described in the table below) of the executive's base salary ("Salary Severance"); (ii) cash incentive severance equal to the sum of (a) the executive's annual target cash incentive compensation opportunity, prorated based on the number of days elapsed in the fiscal year prior to the date of termination, minus the amount of any actual cash incentive award paid to the executive for a semi-annual performance period that occurs during such fiscal year and (b) to the extent the cash incentive award for the prior fiscal year has not been paid as of the date of termination of employment, 100% of the executive's annual target cash incentive compensation opportunity for such prior fiscal year minus the amount of any actual cash incentive award paid to the executive for a semi-annual performance period that occurs during such fiscal year; (iii) health benefit severance equal to a number of months (as described in the table below) multiplied by the monthly COBRA premium required to continue group health, dental and vision coverage for the executive and their eligible dependents ("Health Benefit Severance"); and (iv) vesting acceleration for any time-based equity awards that otherwise would have vested for the specified number of months (as described in the table below) had the executive remained employed with the Company during such period, with equity awards subject to performance-based vesting conditions remaining outstanding and vesting, as to the portion of the award that otherwise would have vested had the executive remained employed with the Company during such period, based on actual achievement of the performance criteria upon the completion of the applicable performance period.

Participant

Salary Severance Health Benefit
Severance
Equity
Acceleration

Executive Officers (including CEO)

100% 12 months 12 months

If an executive's employment is terminated by the Company other than for Cause, death or Disability, or by the executive for "Good Reason" (as defined in the Policy) during the CIC Period, then subject to the executive's timely execution and non-revocation of a separation agreement and release of claims with the Company, the executive will receive: (i) Salary Severance (based on the percentage described in the table below); (ii) cash incentive severance equal to a percentage (as described in the table below) of the executive's annual target cash incentive compensation opportunity ("Cash Incentive Severance"); (iii) Health Benefit Severance (based on a number of months described in the table below); and (iv) vesting acceleration as to 100% of any equity awards that are outstanding and unvested, provided that the treatment of the performance conditions of awards that are subject to performance-based vesting conditions will be as set forth in the individual award agreement.

Participant

Salary Severance Cash Incentive
Severance
Health Benefit
Severance

CEO

200% 200% 24 months

Other Executive Officers

150% 150% 18 months

If any payment or benefit payable to a participant constitutes a "parachute payment" under Section 280G of the U.S. tax code and would be subject to the applicable excise tax, then the participant's payments or benefits will be either (i) delivered in full or (ii) delivered to such lesser extent which would result in no portion of such benefits being subject to the excise tax, whichever results in the receipt by the participant on an after-tax basis of the greatest amount of benefits.

The foregoing description of the Policy does not purport to be complete and is qualified in its entirety by reference to the full text of the Policy, which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On August 20, 2026, the Board adopted amended and restated bylaws of the Company (the "Amended and Restated Bylaws"), effective immediately. Among other things, the amendments effected by the Amended and Restated Bylaws: (i) align the Company's bylaws with recent amendments to the General Corporation Law of the State of Delaware and developments in current practice, including updates regarding notices to stockholders, stockholder lists, and Board action by consent in lieu of a meeting, (ii) clarify quorum and voting standards applicable to meetings of stockholders, (iii) update provisions regarding proxy authorizations, (iv) update provisions regarding the authority to call special meetings of the Board to include the lead independent director, if any, (v) update provisions regarding the representation of securities and interests held by the Company in other entities, (vi) update the Company's indemnification provisions, and (vii) make certain other ministerial, technical and conforming changes.

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, which is filed herewith as Exhibit 3.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

Palo Alto Networks Inc. published this content on August 21, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 21, 2026 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]